New Clot-Busting device could save stroke patients
NCT ID NCT07174505
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests a new device called the CONDA stent retriever, which is used to remove blood clots from the brain in people having a stroke. About 50 patients will be treated within 24 hours of their symptoms starting. The goal is to see if the device is safe and works well at restoring blood flow.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CONDA stent retriever (a device to remove blood clots from brain arteries)
- What this could lead to
- If successful, this could provide a new, safe option for quickly restoring blood flow in stroke patients, potentially reducing disability.
- What could go wrong
- This is an early, small study with only 50 participants, so results may not apply to everyone. There is a risk of bleeding in the brain from the procedure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Semmelweis University Hospital
NOT_YET_RECRUITINGBudapest, 1145, Hungary
-
Vall d'Hebron University Hospital
RECRUITINGBarcelona, 08035, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict stroke recovery?
- Can a drug boost brain recovery after stroke?
- Can a blood Clot's inflammation predict stroke recovery?
- Can a new infusion drug boost stroke recovery?
- Can removing clots from tiny brain arteries boost stroke recovery?
- Could vague stroke symptoms delay lifesaving treatment?